Latest News
Nutrition products company Bellring Brands (NYSE:BRBR) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 18.9% year on year to $588 million. On the other hand, the company’s full-year revenue guidance of $2.3 billion at the midpoint came in 0.7% below analysts’ estimates. Its non-GAAP profit of $0.53 per share was in line with analysts’ consensus estimates.
Via StockStory · May 7, 2025
Via The Motley Fool · May 7, 2025
Via The Motley Fool · May 7, 2025
Investments that perform well in a weak USD environment.
Via Talk Markets · May 7, 2025
Via The Motley Fool · May 7, 2025
Alongside the short-form video experiment, Netflix also announced a redesign of its TV app interface, which aims to simplify navigation and reduce user “eye gymnastics.”
Via Stocktwits · May 7, 2025
Hedera integrates Chainlink CCIP, improves EVM tooling, and unveils HIP proposals in April’s developer highlights.
Via Stocktwits · May 7, 2025
Online health insurance comparison site eHealth (NASDAQ:EHTH) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 21.7% year on year to $113.1 million. The company expects the full year’s revenue to be around $530 million, close to analysts’ estimates. Its GAAP loss of $0.33 per share was 56.6% above analysts’ consensus estimates.
Via StockStory · May 7, 2025
Via The Motley Fool · May 7, 2025
Building operations company Johnson Controls (NYSE:JCI) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 1.4% year on year to $5.68 billion. On top of that, next quarter’s revenue guidance ($6.19 billion at the midpoint) was surprisingly good and 4.3% above what analysts were expecting. Its non-GAAP profit of $0.82 per share was 2.6% above analysts’ consensus estimates.
Via StockStory · May 7, 2025
The S&P 500 is expected to open higher this morning, retracing some of Tuesday's losses.
Via Talk Markets · May 7, 2025
Sarepta stock plummeted Wednesday on a "double whammy" that includes its trimmed 2025 sales outlook and a critical FDA appointment.
Via Investor's Business Daily · May 7, 2025
Banking and retail technology provider Diebold Nixdorf (NYSE:DBD) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 6.1% year on year to $841.1 million. Its GAAP loss of $0.22 per share was significantly below analysts’ consensus estimates.
Via StockStory · May 7, 2025
Shopify stock has retreated 12% in 2025 heading into the company's Q1 earnings report. Amid Trump tariff worries, 2025 guidance will be key.
Via Investor's Business Daily · May 7, 2025